CN Patent
CN118103047A — 铁组合物及其制备和使用方法
Assigned to Vifor International AG · Expires 2024-05-28 · 2y expired
What this patent protects
一种可注射铁组合物,包含包含1mg/mL至约2mg/mL铁的铁(III)‑氢氧化物‑蔗糖复合物,除铁(III)‑氢氧化物‑蔗糖复合物以外的额外的蔗糖,稳定剂(例如氢氧化钠)和水。所述组合物用于治疗贫血。
USPTO Abstract
一种可注射铁组合物,包含包含1mg/mL至约2mg/mL铁的铁(III)‑氢氧化物‑蔗糖复合物,除铁(III)‑氢氧化物‑蔗糖复合物以外的额外的蔗糖,稳定剂(例如氢氧化钠)和水。所述组合物用于治疗贫血。
Drugs covered by this patent
- Injectafer (FERRIC CARBOXYMALTOSE) · Am Regent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.